( Philosophy )
Right Thinking
Proper Care.
Right thinking, right treatment.
SC301 Clinic is a specialized SVF (Stromal Vascular Fraction) medical institution dedicated to righteous progress based on proper medical care.
We aim to be a hospital where the process and standards of medical care are upright first, rather than a hospital that merely produces results.
SC301 constantly researches to restore women's health through SVF and create natural beauty that is close to their inherent nature.
We view SVF not as a simple procedure, but as a clinical paradigm.
Correction
Susumu
Correct · Advance
(The Story Behind 301 SVF Treatment Approaches)
'301 Ways' is not a single fixed answer, but a process of finding the most correct solution tailored to each individual patient.
( SVF Treatment Categories )
Stem cell treatment Four areas.
The SVF Story Toward 301 SVF Treatment Methods — Transcending the boundaries between cosmetic and medical care, we expand the paradigm of treatment to include rare and intractable diseases.
01 — Aesthetic
cosmetic surgery
Restoration of natural aesthetics
- SVF breast augmentation
- SVF facial fat grafting
- SVF Body Contouring
02 — Anti-aging
anti-aging
Body age reversal to cells
- Anti-aging cell injection
- Anti-aging regenerative treatment
- SVF Cell Banking (Cell Storage)
03 — Pain Care
Pain treatment
Recovery via homing effect
- knee degenerative arthritis
- Shoulder arthritis · Rotator cuff
- SVF injection treatment by site
04 — Rare Disease
intractable diseases
New possibilities of SVF
- hair loss
- Erectile dysfunction
- Clinical research on dementia, etc.
( The Numbers )
Numbers prove
19 Years of Belief.
To focus on a maximum of only 2 to 3 patients a day, I have researched a single field for 19 years. The numbers are the promise we have kept.
Since
2006
Time spent researching only the field of SVF
Cases
9000
19-year cumulative SVF surgery record
Engraftment
77.48
Average engraftment rate listed in SCI-indexed academic journals
Per day
3
Focus on a maximum of only 2 to 3 patients per day
Numbers are a promise. The belief SC301 has upheld for 19 years.
Shin Dong-jin Representative Director
( The Doctor )
Shin Dong-jin,
MD, Ph.D.
Shin Dong-jin Representative Director · SC301 Clinic
Up to 2 to 3 minutes of surgery per day.
Not once in 19 years
It is an unwavering principle.
Hello, this is Shin Dong-jin, Chief Director of SC301 Clinic.
Focus on a single field for 19 yearsThrough over 9,000 surgeries, we have been able to be a part of the start of new lives for many customers.
SVF breast augmentation is currently the surgical method that can best medically replicate the shape of a natural breast. The SC301 is Performs a maximum of only 2 to 3 surgeries per dayThis is a belief I have upheld for 19 years to focus on the patient and the surgery.
View Full Credentials
Graduated with a Ph.D. in Medicine from Korea University
Current Chief Director of SC301 Clinic
Former Director of Apgujeong Tiara Clinic
Former President of the Korean Society of Stem Cell Plastic Surgery
Regular member of the Korean Society of Aesthetic Plastic Surgery
Regular member of the Korean Surgical Society
Judges of the World Invention and Creativity Olympics
Asia LOHAS Certification Judge
Director of the Korea University Invention Association
Miss Intercontinental Body Line category judge
( Philosophy )
SC301 Clinic
The chief director is different.
SC301 is not a hospital that uses learned technology, but a hospital that has set the standards for technology.
01
Stem Cells
19
19
A specialist who has dedicated 19 years to a single path and researched only one field
02
Korean Society of Stem Cell Plastic Surgery 10 years as chairman
The leader who led the SVF Plastic Surgery Alliance
03
international academic papers Part 2 listed
1 Oxford Journal · 1 SCI International Journal
04
Live surgery 15 years of reading
Personally led dozens of live surgeries
( Journal )
The Chief Director's SCI international academic journals and Oxford
Please check the paper.
SVF, a specialist who has researched exclusively in one field, with 1 article in an Oxford journal and 1 article in an SCI international academic journal.
I am a specialist who has performed 9,000 SVF surgeries and recorded an average engraftment rate of 77.48%.
01
Oxford journal
Oxford-published academic journal Stem Cells
Research paper presentation.
The publication of a paper on the stem cell research results of Chief Director Shin Dong-jin in the Oxford University journal is the first paper to introduce the academic foundation of SVF treatment to the international stage.
02
SCI Journal
SCI-level international academic journal
Listed with a survival rate of 77.48%.
Proven an average engraftment rate of 77.48% 18 months after the procedure. This is an SCI international academic journal paper that is the only one in Korea to successfully register the precise surgical method and engraftment rate figures for stem cell fat grafting.
( Trained by SC301 )
A hospital that
teaches surgeons.
Hospital that teaches doctors, SC301.
Chief Director Shin Dong-jin served as the president of the Korean Society of Stem Cell Plastic Surgery, an association of SVF clinics, for over 10 years, and
For the past 15 years, I have personally led dozens of live surgeries, lectures, and discussions.
SC301 is not a hospital that uses learned technology, but a hospital that has set the standards for technology.
- - 01.15 years of live surgery reading
- - 02.Served as President of the Korean Society of Stem Cell Plastic Surgery for 10 years
- - 03.2 international academic papers published (Oxford 1 · SCI 1)
- - 04.Numerous lectures at domestic and international academic conferences and seminars
( Why Shin Dong-jin )
Directly taught by the Head Director
Tips for Choosing an SVF Breast Augmentation Clinic
'Published a paper on stem cell research results in Oxford, UK', '9,000 cases', 'Published a paper on an average engraftment rate of 77.48% in an SCI-indexed journal'.
I will explain, based on four criteria, why SC301 is the answer when it comes to SVF breast augmentation.
SC301 PLASTIC SURGERY
Shin Dong-jin,
MD, Ph.D.
Hello, I am Shin Dong-jin, Chief Director of SC301 Clinic. Through 19 years of focused dedication to a single field, I have been able to help many patients start a new life through over 9,000 surgeries.
I am embarrassed to say this myself, but perhaps thanks to results such as 'publication of a stem cell research paper at Oxford, UK,' '9,000 cases,' and 'publication of a paper on an average engraftment rate of 77.48% in a world-class SCI-level academic journal,' many people seek out the SC301 when considering SVF breast augmentation.
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
SC301 PLASTIC SURGERY ·
( The Lab )
A research institute,
quietly working inside our clinic.
There is always a research institute next to SC301's consultation room.
SC301 SVF Research Institute, which started in Korea for the first time in 2007, is a place that continuously conducts research to increase the engraftment rate by just 1%.
Based on data from the analysis of 9,000 cases at our in-house research institute, professional researchers with master's or doctoral degrees and over 10 years of experience, rather than nursing assistants
SVF extraction is performed manually according to the SVF major protocol.
LAB
SVF Research Lab
Domestic SVF Research Institute
A dedicated SVF research institute launched in Korea in 2007. It analyzes 9,000 cases in its own laboratory.
establish
2007
Cumulative cases
9,000+ cases
Exclusive equipment
University hospital-level 10+ types
Target engraftment rate
100 %
- SINECE 2007 SVF Dedicated Research Laboratory
- Analysis of 9,000 cases using in-house data
- Possess university hospital-grade SVF dedicated equipment
DR
Expert Researchers
10+ years of Master's and Ph.D. research experience
Professional researchers with master's or doctoral degrees and over 10 years of experience perform SVF extraction manually.
Researcher qualification
Master's and Doctoral degrees
Average experience
Over 10 years
Extraction method
Professional handiwork
protocol
SVF major
- Professional researchers with master's or doctoral degrees and over 10 years of experience
- Direct extraction according to the SVF major protocol
- Nursing assistants not operating · Professional personnel only
RN
Sterile System
sterile surgical system
Sterile medical facilities and a sterile surgical system. All nursing staff are registered nurses (RNs).
medical facilities
100% sterile
surgical system
Aseptic surgery
Nursing staff
Registered Nurse
nursing assistant
Non-operation
- 100% Sterile Treatment Facilities · Sterile Surgical System
- 100% Registered Nurse (RN) operation, No Nursing Assistants
- Standard protocol for minimizing infection
( Heritage )
Having set the standard for 19 years
The Footsteps of SC301.
From the start of my medical career in 1999 to the designation as an Advanced Regenerative Medicine Institution in 2026, this is the time SC301 has spent setting the standards for SVF.
Click on each year to see the story of that period.
2026
“Now licensed as a regenerative medicine institution.”
-
2026
- Designation as an Advanced Regenerative Medicine Implementing Institution (No. Regeneration-1-0049)
- Cell Processing Facility Permit (No. 139)
2025 - 2020.
“Validated, awarded, internationally published.”
-
2025
- Gangnam-gu Medical Tourism Partner Agency Selection
- Premium Membership Center Opening
-
2023
- SCI Paper Listed — Average engraftment rate of 77.48% 18 months after procedure
-
2020
- Stem cell breast augmentation listed in Oxford Journal
2019 - 2016.
“Awarded by ministries, recognized globally.”
-
2019
- SVF engraftment videos surpass 6,000 views
- Miss Intercontinental Body Line category judge
- Participation in the Stem Cell Plastic Surgery Section of the China Ningbo World Plastic Surgery Expo
-
2018
- Proud Korean People Award Winner in the Medical Development Sector
- Received the Ministry of Health and Welfare Chairman's Award
- Winner of the Bridge Economy Newspaper President's Award at the Medical Consumer Satisfaction Awards
-
2017
- Winner of the Korea Brand Model Grand Prize
- Awarded the Medical Consumer Satisfaction Grand Prize
- Super Bowl MVP football player Hines Ward and his wife visit
- Pearl Buck Foundation Sponsorship for Mixed-Race Children
-
2016
- SC301 Dermatology Extended Treatment
- Application for trademark registration of VBA Stem Cell Breast Augmentation, Corevo, Kokkok Point Liposuction, etc.
2015 - 2010.
“Publishing the science of SVF, paper by paper.”
-
2015
- Introduction of sterile surgical system
- Third paper on 8,000-cell stem cell breast augmentation published, proving a 76% engraftment rate
- ASIA LOHAS Foods Wins KFDA Commissioner's Award for Invention
-
2014
- SVF Anti-Aging Cell Injection Post-Clinical Procedure
- The 3rd ASIA LOHAS Food & Environment Invention Awards — Minister of Health and Welfare Award Presented
- Director Shin Dong-jin, Incheon Asian Para Games Torch Relay
-
2013
- 2nd International Paper on Stem Cell Plastic Surgery Released — Fat Survival Rate Proven at Over 70%
- Introduction of TGI / Cellcount Equipment
- Yonsei University Gangnam Severance SVF Treatment MOU
- Invited Lecture at the Korea-China Stem Cell Plastic Surgery Society Forum
-
2012
- June Korean Society of Stem Cell Plastic Surgery — Live Seminar on SVF Plastic Surgery, from Understanding to the Latest Insights and Practical Techniques
- 1st International Paper Presentation on SVF Plastic Surgery in August — Analysis of Clinical Effects of Body Fat Grafting Using Fat SVF
- September Public Seminar of the Korean Society of Stem Cell Plastic Surgery — Intensive Media Coverage Including Chosun Ilbo and JoongAng Ilbo
- Second Paper — Breast Augmentation Using Adipose-Derived Stem/Stromal Cells and Autologous Fat Grafting
- Introduction of Huricell equipment
-
2011
- Introduction of car stations and technological advancements
- Winner of the E-BIZ Brand Award in the Medical/Health Plastic Surgery Category
- Skin SVF Regeneration Center Opens
- Korean Society of Aesthetic Plastic Surgery — Stem Cell Breast Augmentation Announcement
- Winner of the 2011 Premium Brand Grand Prize selected by female consumers
- 17 Concert of Love — Supporting Underprivileged Multicultural Families with Hines Ward
-
2010
- Various clinical applications using SVF
- Miae-ro Women's Medicine Conference — Invited Lecture on Stem Cell Breast Augmentation
- Baekbeom Memorial Hall Korean Society of Aesthetic Plastic Surgery Grand Symposium — Presentation on Stem Cell Breast Augmentation
- APACS International Congress of Aesthetic Plastic Surgeons — First Announcement of Stem Cell Breast Augmentation
- Publication of international papers and intensive research with Shandong University School of Medicine
2009 - 1999.
“The beginning of a single-minded pursuit.”
-
2009
- Founded the Korean Society of Stem Cell Plastic Surgery and served as its president
- Korean International Society of Aesthetic Plastic Surgery Seminar — Presentation on the Efficacy and Safety of Stem Cell Breast Augmentation
- 53rd Seoul International Congress of Aesthetic Plastic Surgery Seminar — Presentation on Clinical Effects of Stem Cell Breast Augmentation
-
2008
- SVF Begins Full-Scale Procedures on Chest, Face, Hands, and More
-
2007
- SVF Medical Group SC301 established (formerly Apgujeong Tiara)
- Korea's first SVF breast augmentation procedure
-
2006
- Research on SVF treatment
- Introduction and establishment of fat grafting and liposuction in Korea
-
1999
- Early medical career and foundation building
( Awards )
Proven by numerous awards
Medical competitiveness.
SVF has been recognized for its contribution to the development of plastic surgery through 11 awards over 13 years, from the 2011 E-BIZ Brand Award to the 2024 Medical Asia Award.
2017 Korea Brand Model Awards
2015, 2016 Minister of Food and Drug Safety Award
2016 Medical Consumer Satisfaction Award
2017 Minister of Health and Welfare Award
2024 Medical Asia Awards
( National Certifications )
State-certified
SC301 qualification.
In 2026, SC301 simultaneously obtained designation as an advanced regenerative medicine implementing institution and approval for a cell processing facility from the Ministry of Health and Welfare.
It is not a mere award, but a 'real' SVF medical qualification granted by the state.
— Advanced Regenerative Medicine
Designation as an Advanced Regenerative Medicine Implementing Institution.
Officially designated by the Ministry of Health and Welfare — No. 1-0049
— Cell Processing Facility
Cell processing facility permit.
Officially authorized by the Ministry of Health and Welfare — No. 139
( The Difference )
The patient's cells, Outside the hospital
Not taking a single step.
Within a state-certified facility, without outsourcing to external companies — SC301 handles everything from patient cell collection to purification and transplantation.
We process everything in-house as a one-stop service under an independent internal quality control system within the medical institution.
A Question To The Patient
The cells in my body, Would you like to entrust this?
Or the hospital performing the surgery
To take direct responsibility until the end Do you want it?
“Would you trust your own cells to a third-party facility —
or have the surgeon who operates on you take full responsibility, from start to finish? ”
Shin Dong-jin · SC301 PLASTIC SURGERY
( SC301 ONE-STOP SYSTEM )
General SVF treatment structure vs. SC301's one-stop self-processing.
It is not easy for some hospitals to even have an internal lab.
Even if it physically exists, after collecting the patient's tissue, it is legally entrusted to a separate company for processing.
It is a resupply structure. SC301 directly controls every stage of that flow within the medical institution.
— Common Practice
general hospital
SVF treatment structure.
- - 01. Patient tissue (fat) collection at the hospital
- - 02. Entrusted to a legally separate entity (bio company)[ Move out of the hospital ]
- - 03. Cell processing and purification at external facilities
- - 04. Transplanted after being supplied back to the hospital[ Decentralization of Control ]
The entities responsible for the cells are the hospital and the external contractor.
Dualized distributed structure.
Dualized distributed structure.
— The SC301 Way
SC301's One-stop
Self-processing structure.
- - 01. Patient tissue collection in SC301 examination room
- - 02. SC301 internal laboratory processing[ Inside the hospital ]
- - 03. SC301's in-house laboratory handles the entire purification process.
- - 04. Direct transplantation from SC301 · Full responsibility until the end[ Not taking a single step ]
From harvesting to transplantation SC301is
An integrated structure that takes full responsibility to the end.
An integrated structure that takes full responsibility to the end.
Why this license matters
Not a general biotech company,
Cell processing facility permit obtained by the lawmaker.
The cell processing facility permit is originally General biotech companiesEven meeting this is a strict standard.
And a general lawmaker passes all of the Ministry of Food and Drug Safety's standards.
The work of constructing facilities and obtaining permitsIt differs in its difficulty and symbolism.
SC301 has passed all those standards and from the Ministry of Health and Welfare in 2026
Cell Processing Facility Permit (No. 139)and
Designation as an Advanced Regenerative Medicine Implementing Institution (No. Regeneration-1-0049)of
We obtained it simultaneously. This is the result of the government certifying what constitutes the qualification for 'genuine' SVF medical practice.
Cleanroom · Cleanroom
HVAC System · Air Conditioning Facility
Sterility Testing · Sterility Test
Independent QC · Independent Quality Control
( three differences )
SC301's self-processing creates Three differences.
Real-time control beyond physical distance, complete responsibility without external outsourcing, and know-how accumulated over years of managing tens of millions of cells.
— Value 01
Responsibility & Control
Responsibility and control.
Cell collection, purification, and transplantation Within the legal boundaries of a medical institution It ends. A structure directly controlled by medical staff without external outsourcing — where the responsibility for disputes is not dispersed, The director takes full responsibility for the surgery until the end.
— Value 02
Beyond Physical Distance.
Beyond physical distance.
A researcher affiliated with the hospital and the director performing the surgery Communicate in real time...because key variables of cell purification are tuned on the spot, to improve engraftment rates In a favorable position Medical staff can control it directly.
— Value 03
Tens of Millions of Cells.
Know-how for managing tens of millions of cells.
Analyzing 9,000 cases over 19 years since opening the SVF Research Institute in Korea in 2007 Manage and store tens of millions of cellsThe time spent. Refining know-how is accumulated only through time, and that time is proven by the clinical results of SC301.
( The Return )
And in the end,
SC301.
In the end, again, SC301.
After a mix of anticipation and disappointment, Those who have come a long way to knock on SC301's doorThere is.
The single word they all say in unison.
" I made the right choice here. "
— A common remark from those who came for revision surgery
( three regrets )
Making you take the long way around Three regrets.
The true standard of high-end that becomes visible only after experiencing failure.
-
— Regret 01The Implant
Discomfort.Foreign body sensation from the implant.
-
— Regret 02A Disappointing
Engraftment.Disappointing graft survival rate.
-
— Regret 03The Limit
of Design.Limitations of design.
( The Wisest Decision )
So that there is no second pain or regret, Don't come the long way around.
An uncompromising difference in engraftment rates. Safety proven by in-hospital sterile cell processing facilities.
The wisest decision for the most certain result.
From the beginning, SC301.
From beginning to end,
SC301 is with you.
Shin Dong-jin, MD, Ph.D.
Shin Dong-jin · SC301 Chief Director
SC301 PLASTIC SURGERY
SC301 is I do not follow trends. Create standards.
SC301 Doesn't follow trends. It sets the standard.
Specialty
Point 01
Experience working with SVF
SC301 Chief Director Shin Dong-jin is a specialist who has researched exclusively in the field of SVF. He is a specialist who has published a paper on stem cell research results at Oxford, UK, performed 9,000 SVF surgeries, and recorded an average engraftment rate of 77.48%.
Point 02
Hospitals with research institutes and researchers
Based on analysis data from 9,000 cases at the laboratory, SVF specialists with over 10 years of experience manually perform SVF extraction according to the protocol.
Point 03
Clinic Hours · Directions
SC301 operates on a 100% reservation-only basis. Please visit after completing the Q&A on the pre-consultation questionnaire sent via KakaoTalk after making a reservation.
Phone Consultation/Reservation
Directions
3rd~4th Floors, B1, Chan & Chan Tower, 611 Yeongdong-daero (77-9 Samseong-dong), Gangnam-gu, Seoul
Consultation Inquiry Guide
Point 01
Experience working with SVF
SC301 Chief Director Shin Dong-jin is a specialist who has researched exclusively in the field of SVF. He is a specialist who has published a paper on stem cell research results at Oxford, UK, performed 9,000 SVF surgeries, and recorded an average engraftment rate of 77.48%.
Point 02
Hospitals with research institutes and researchers
Based on the analysis data from 9,000 cases at the laboratory, SVF extraction is performed manually according to the protocol by professional researchers with over 10 years of experience, rather than nurses or nursing assistants.
Point 03
Clinic Hours · Directions
SC301 operates on a 100% reservation-only basis. Please visit after completing the Q&A on the pre-consultation questionnaire sent via KakaoTalk after making a reservation.
Phone Consultation/Reservation
Directions
3rd~4th Floor, Chan & Chan Tower, 611 Yeongdong-daero (77-9 Samseong-dong), Gangnam-gu, Seoul
Consultation Inquiry Guide
